TLR2 and Insulin resistance: Given that biglycan is released from the ECM under conditions of tissue stress and that unsequestered biglycan is an endogenous ligand for TLR2/4, the relevance of the current findings to the pathogenesis of obesity-related disorders such as insulin resistance warrant further studies.